Abstract
The enzyme BACE (β-site APP-cleaving enzyme) has recently been identified as the β-secretase that cleaves the amyloid precursor protein (APP) to produce the N terminus of the Aβ peptide found in plaques in the brains of Alzheimer's disease patients. BACE is an aspartic protease similar to pepsin and renin. Comparative modeling of the three-dimensional structure of BACE in complex with its substrate shows that several residues confer specificity of the enzyme for APP. In particular, Arg296 forms a salt-bridge with the P1' Asp of the APP substrate, explaining the unusual preference of BACE among aspartic proteases for a P1' residue that is negatively charged. Several hydrophobic residues in the enzyme form a pocket for the P1 hydrophobic residue (Met in wild-type APP and Leu in APP with the 'Swedish mutation' associated with early-onset of Alzheimer's disease). Inhibitors that can bind to the BACE active site may prove useful for drugs to treat and prevent Alzheimer's disease. (C) 2000 Academic Press.
Original language | English |
---|---|
Pages (from-to) | 241-248 |
Number of pages | 8 |
Journal | Journal of Molecular Biology |
Volume | 300 |
Issue number | 2 |
DOIs | |
State | Published - Jul 7 2000 |
Keywords
- Alzheimer Disease/enzymology
- Amino Acid Sequence
- Amyloid Precursor Protein Secretases
- Amyloid beta-Protein Precursor/chemistry
- Animals
- Arginine/metabolism
- Aspartic Acid Endopeptidases/chemistry
- Aspartic Acid/metabolism
- Binding Sites
- Crystallography, X-Ray
- Endopeptidases
- Humans
- Hydrogen Bonding
- Models, Molecular
- Molecular Sequence Data
- Mutation
- Protein Conformation
- Sequence Alignment
- Static Electricity
- Substrate Specificity